Top

Published in:

01-04-2022 | Cardiomyopathy | ORIGINAL ARTICLE

Cardiac fibroblast activation in dilated cardiomyopathy detected by positron emission tomography

Authors: Ximin Shi, MD, Xue Lin, MD, Li Huo, MD, Xiang Li, MD

Published in: Journal of Nuclear Cardiology | Issue 2/2022

Excerpt

Chronic heart failure (CHF) related to dilated cardiomyopathy is characterized by impaired cardiac contractile dysfunction induced by imbalance inflammation and fibrosis activation.1 …

Frangogiannis NG (2019) Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities. Mol Aspects Med 65:70-99. https://doi.org/10.1016/j.mam.2018.07.001CrossRefPubMed

van der Meer P, Gaggin HK, Dec GW (2019) ACC/AHA versus ESC guidelines on heart failure: JACC Guideline Comparison. J Am Coll Cardiol 73:2756-2768. https://doi.org/10.1016/j.jacc.2019.03.478CrossRefPubMed

Tarkin JM, Joshi FR, Evans NR, Chowdhury MM, Figg NL, Shah AV et al (2017) Detection of atherosclerotic inflammation by (68)Ga-DOTATATE PET compared to [(18)F]FDG PET Imaging. J Am Coll Cardiol 69:1774-1791. https://doi.org/10.1016/j.jacc.2017.01.060CrossRefPubMedPubMedCentral

Title: Cardiac fibroblast activation in dilated cardiomyopathy detected by positron emission tomography
Authors: Ximin Shi, MD
Xue Lin, MD
Li Huo, MD
Xiang Li, MD
Publication date: 01-04-2022
Publisher: Springer International Publishing
Keywords: Cardiomyopathy
Molecular Imaging
Heart Failure
Chronic Heart Failure
Published in: Journal of Nuclear Cardiology / Issue 2/2022
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI: https://doi.org/10.1007/s12350-020-02315-w

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Cardiac fibroblast activation in dilated cardiomyopathy detected by positron emission tomography

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2022

Correction to: Relation between myocardial blood flow and cardiac events in diabetic patients with suspected coronary artery disease and normal myocardial perfusion imaging

Coexistent transthyretin amyloid cardiomyopathy and monoclonal gammopathy: Diagnostic challenges and prognostic implications

Assessment of cerebral glucose metabolism in patients with heart failure by 18F-FDG PET/CT imaging

Importance of individual patient characteristics when assessing the ability of cardiac adrenergic imaging to guide ICD use

Integrating baseline electrocardiography and myocardial perfusion imaging

Quantitative myocardial perfusion 82Rb-PET assessed by hybrid PET/coronary-CT: Normal values and diagnostic performance